DPP-4 Inhibitors Surged, RA Treatments Maintained Strong Growth in FY2011

June 15, 2012
A survey conducted by Jiho, Inc. of the 100 top-selling ethical drugs from domestic companies in the domestic market by therapeutic category shows that dipeptidyl peptidase-4 (DPP-4) inhibitors surged, while rheumatoid arthritis (RA) treatments continued to show strong sales in...read more